RCT on NPWT for Incisions Following Major Lower-limb Amputation to Reduce Surgical Site Infection
Single Center Prospective Randomized Control Trial on Negative Pressure Wound Therapy for Incisions Following Major Lower-limb Amputation to Reduce Surgical Site Infection
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Amputations are common vascular surgery procedures performed on patients with multiple medical comorbidities. Historically, morbidity and mortality following major amputation of the lower extremity in this patient population has been high. Recent studies have cited 30-day mortality rates ranging from 6% to 17%, with greater risk among patients with transfemoral vs transtibial amputation. Postoperative goals after amputation include uncomplicated wound healing and, for appropriate candidates, progression to use of a prosthesis for ambulation or transfer. Perioperative wound complications can be devastating in this already debilitated population and can range from 13% to 40%.
Postoperative wound complications, such as infection, dehiscence, and formation of haematoma or seroma, are common complications of surgical procedures; particularly among patients with risk factors such as obesity and diabetes. Wound complications may delay recovery, increase patient discomfort and reduce overall quality of life. Increased healthcare costs may be incurred due to prolonged inpatient stay, repeat surgery and the need for increased follow-up.
Wounds that are secondary to amputation are reported in 13-40% of cases and are one of the most challenging types of lower extremity wounds to heal. These patients often have compromised healing capacity. Kayssi et al studied Canadian readmission rates, early (<30 days) and late (30-365) readmissions were attributed to stump complications in 13% and 10% of patients respectively.
Wound complications in major limb amputation frequently result in the need for further major surgery in a group of patients with significant co-morbidity and enhanced operative risk. 1, 3, and 5 year reamputation rates for diabetics who have had major amputations are 4.7%, 11.8%, and 13.3% respectively. Henry et al suggested that undergoing multiple amputation revisions may indicate aggressive measures to treat critical limb ischemia or chronic infection that precede conversion to a more proximal amputation. Kono et al studied the incidence and risk factors for reamputation after forefoot amputation. They found that 16/116 (14%) patients developed postoperative infection, and 10 of these required reamputation (62.5%). Five of the ten reamputations occurred within 30 days after the patients developed postoperative infections.
In addition to the morbidity from infection there is also an increased rate of phantom pain as well as a delay to mobilisation with prosthesis. Minimizing postoperative infections would likely have improvements in clinical outcomes, quality of life, and utilization of resources. Currently, all patients are given prophylactic broad spectrum antibiotics to reduce the incidence of wound infection. Sadat et al investigated whether a prolonged 5 day course of antibiotics wound reduce stump infections, their results were positive however this treatment is associated with the increased risk of antimicrobial resistance and c. difficile infection.
Negative-pressure wound therapy (NPWT) has traditionally been used for the treatment of open wounds. In recent years, the indication for NPWT has been extended to include treatment of closed surgical incisions. Armstrong et al conducted a randomized controlled trial to determine whether NPWT delivered by the VAC system was clinically efficacious in treating amputation wounds of the diabetic foot to improve the proportion of wounds with complete closure. Treatment with NPWT resulted in a higher proportion of wounds that healed, faster healing rates, and fewer re-amputations than with standard treatment. No randomized controlled trials have been performed to assess NPWT and infection rates after major lower limb amputation.
There is a paucity of scientific literature reporting outcomes following major amputation in patients with critical limb ischemia, particularly with regards to wound problems and infection. The purpose of this study is to provide Level I evidence on whether negative pressure wound therapy is an effective strategy to significantly reduce postoperative infections after major lower extremity amputation, thereby reducing patient morbidity and mortality from this procedure.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Oonagh Scallan, MD
- Phone Number: 6478761954
- Email: oonagh.scallan@lhsc.on.ca
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- any patient 18 years or older undergoing amputation of the lower limb, either an above knee amputation (AKA) or below knee amputation (BKA)
- ability to read and write English to undergo informed consent
Exclusion Criteria:
- patients in which a complete seal cannot be obtained at the time of vacuum placement
- wounds that are not closed primarily
- existing infection
- patient is anticipated to not follow-up
- inability to read and write English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Negative pressure wound therapy
A vacuum assisted closure device will be applied in this arm
|
Negative pressure wound therapy is a commonly utilized tool in the hospital setting and will be applied to amputations in our study to determine the effect on surgical site infections
|
|
Other: Standard dressing
Standard dressing will be applied to this arm
|
A standard dressing will be applied to the amputations in this arm of the study
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surgical site infection
Time Frame: 30 days
|
Surgical site infection will be defined using the Centre for Disease Control and Prevention Guidelines.
|
30 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of stay
Time Frame: 30 days
|
length of hospital stay
|
30 days
|
|
Antibiotic use
Time Frame: 30 days
|
requirement for antibiotics to treat surgical site infection
|
30 days
|
|
Reoperation
Time Frame: 30 days
|
requirement for revision of amputation
|
30 days
|
|
Death
Time Frame: 30 days
|
mortality
|
30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Adam Power, MD, London Health Sciences Centre
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- REB 109128
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infection
-
NCT05977868TerminatedSkin and Soft Tissue Infection | Gastrointestinal Infection | Pulmonary Infection | Bone and Joint Infection | Endovascular Infection | Genitourinary Infection
-
NCT06402591Active, not recruitingSurgical Site Infection | Joint Infection | Infection, Surgical Site | Infection Prosthesis Hip and Knee | Infection, Prosthesis Related | Infection Pro
-
NCT05797818CompletedSurgical Site Infection | Nosocomial Infection | Healthcare Associated Infection
-
NCT05021315RecruitingPostoperative Infection | Cesarean Section Complications | Vaginal Infection
-
NCT00975377CompletedSurgical Site Infection | Superficial Surgical Site Infection | Deep Surgical Site Infection | Organ/Space Surgical Site Infection
-
NCT03284749CompletedSurgical Site Infection | Wound Infection | Cesarean Section; Infection | Perineal Infection
-
NCT06172010RecruitingProsthetic-joint Infection | Infection Hip | Infection; Knee, Joint
-
NCT04618276CompletedProsthetic Joint Infection | Surgical Site Infection | Prosthesis and Implants | Postoperative Wound Infection Deep Incisional Surgical Site
-
NCT04067843CompletedProsthetic Joint Infection | Surgical Site Infection | Prosthesis and Implants | Postoperative Wound Infection Deep Incisional Surgical Site
-
NCT06728930Enrolling by invitationLatent Tuberculosis Infection | Tuberculosis Infection, Latent
Clinical Trials on Negative pressure wound therapy
-
NCT05805046WithdrawnSurgical Wound, Recent | Trauma-related Wound | Dehiscence Wound | Surgical Wound Leak
-
NCT07258134CompletedSurgical Site Infection | Wound Heal | Negative-Pressure Wound Therapy | Stoma Site Infection
-
NCT03935659WithdrawnSurgical Site Infection | Groin Infections
-
NCT07040683RecruitingPostoperative Complications | Surgical Wound Infection | Skin Cancer | Wound Healing | Bandages | Negative-Pressure Wound Therapy | Skin Grafting | Lower Extremity | Skin Transplantation | Split Thickness Skin Graft
-
NCT05481398CompletedSurgical Site Infection | Hepatobiliary Disease | Hepatobiliary Disorders
-
NCT03942575CompletedBreast Cancer | Wound Infection | Wound Complication | Wound Dehiscence | Wound Necrosis
-
NCT04955730Active, not recruitingSurgical Wound Infection
-
NCT07120386RecruitingNecrotizing Soft Tissue Infections
-
NCT06647290RecruitingWound Healing | Pilonidal Sinus